Anthropic Acquires AI Biotech Startup Coefficient Bio in $400 Million Stock Deal, Bolstering Healthcare Push
Summary
Anthropic acquires stealth AI biotech startup Coefficient Bio in a $400 million stock deal, bringing the 10-person team behind an AI-driven drug discovery platform into its health and life sciences division, accelerating the company's growing push into healthcare.
Key Points
- Anthropic acquires stealth biotech AI startup Coefficient Bio in a $400 million stock deal, with sources confirming the transaction has closed.
- The acquisition accelerates Anthropic's push into healthcare and life sciences, building on its October launch of Claude for Life Sciences, a tool designed to assist scientific researchers.
- Coefficient Bio, founded eight months ago by Samuel Stanton and Nathan C. Frey — both veterans of Genentech's Prescient Design — used AI to streamline drug discovery, and its roughly 10-person team is set to join Anthropic's health and life sciences division.